Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing

G. J. van Baaren, M. M. C. Bruijn, B. W. Mol

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Citations (Scopus)

Original language	English
Pages (from-to)	142-143
Journal	American Journal of Obstetrics and Gynecology
Volume	218
Issue number	1
Early online date	2017
DOIs	https://doi.org/10.1016/j.ajog.2017.10.037
Publication status	Published - 2018

Access to Document

@article{b6dcc703d74d43ceb78881b2923e9fce,

title = "Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing",

author = "{van Baaren}, {G. J.} and Bruijn, {M. M. C.} and Mol, {B. W.}",

year = "2018",

doi = "https://doi.org/10.1016/j.ajog.2017.10.037",

language = "English",

volume = "218",

pages = "142--143",

journal = "American Journal of Obstetrics and Gynecology",

issn = "0002-9378",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing

AU - van Baaren, G. J.

AU - Bruijn, M. M. C.

AU - Mol, B. W.

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85039436655&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/29305007

U2 - https://doi.org/10.1016/j.ajog.2017.10.037

DO - https://doi.org/10.1016/j.ajog.2017.10.037

M3 - Comment/Letter to the editor

C2 - 29305007

SN - 0002-9378

VL - 218

SP - 142

EP - 143

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

IS - 1

ER -